Cargando…
Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission
OBJECTIVE: To investigate peripheral blood lymphocyte subpopulations, particularly helper T (Th) cells and cytokine expression before and after treatment in polymyositis (PM) and dermatomyositis (DM). PATIENTS AND METHODS: Ten patients with PM and 15 with DM were enrolled in this study. As a control...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480870/ https://www.ncbi.nlm.nih.gov/pubmed/23115480 http://dx.doi.org/10.4137/CMAMD.S10272 |
_version_ | 1782247641005948928 |
---|---|
author | Shimojima, Yasuhiro Ishii, Wataru Matsuda, Masayuki Ikeda, Shu-ichi |
author_facet | Shimojima, Yasuhiro Ishii, Wataru Matsuda, Masayuki Ikeda, Shu-ichi |
author_sort | Shimojima, Yasuhiro |
collection | PubMed |
description | OBJECTIVE: To investigate peripheral blood lymphocyte subpopulations, particularly helper T (Th) cells and cytokine expression before and after treatment in polymyositis (PM) and dermatomyositis (DM). PATIENTS AND METHODS: Ten patients with PM and 15 with DM were enrolled in this study. As a control we used 11 age-matched healthy subjects. We analyzed peripheral blood lymphocytes using flow cytometry. Serum cytokines were determined by enzyme-linked immunosorbent assay. RESULTS: Th2/Th1 and Th2/Th17 ratios were significantly higher in both PM and DM than in controls and this Th2-predominancy is marked in DM associated with interstitial pneumonia. IL-1β, IL-6 and TGF-β were significantly higher in both PM and DM and IL-4 showed a significant increase in DM when compared to controls. There was no significant correlation between either any lymphocyte subpopulations or serum cytokines and clinical severity markers such as the manual muscle strength test, serum creatine kinase, and the total CT score. Th2/Th17 in both PM and DM, as well as Th2/Th1 in the latter, significantly decreased after clinical remission compared with before treatment. CONCLUSIONS: Th2-predominancy as shown by the increase in Th2/Th1 and Th2/Th17 ratios may suggest active disease in PM/DM but does not reflect clinical severity. |
format | Online Article Text |
id | pubmed-3480870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-34808702012-10-31 Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission Shimojima, Yasuhiro Ishii, Wataru Matsuda, Masayuki Ikeda, Shu-ichi Clin Med Insights Arthritis Musculoskelet Disord Original Research OBJECTIVE: To investigate peripheral blood lymphocyte subpopulations, particularly helper T (Th) cells and cytokine expression before and after treatment in polymyositis (PM) and dermatomyositis (DM). PATIENTS AND METHODS: Ten patients with PM and 15 with DM were enrolled in this study. As a control we used 11 age-matched healthy subjects. We analyzed peripheral blood lymphocytes using flow cytometry. Serum cytokines were determined by enzyme-linked immunosorbent assay. RESULTS: Th2/Th1 and Th2/Th17 ratios were significantly higher in both PM and DM than in controls and this Th2-predominancy is marked in DM associated with interstitial pneumonia. IL-1β, IL-6 and TGF-β were significantly higher in both PM and DM and IL-4 showed a significant increase in DM when compared to controls. There was no significant correlation between either any lymphocyte subpopulations or serum cytokines and clinical severity markers such as the manual muscle strength test, serum creatine kinase, and the total CT score. Th2/Th17 in both PM and DM, as well as Th2/Th1 in the latter, significantly decreased after clinical remission compared with before treatment. CONCLUSIONS: Th2-predominancy as shown by the increase in Th2/Th1 and Th2/Th17 ratios may suggest active disease in PM/DM but does not reflect clinical severity. Libertas Academica 2012-10-18 /pmc/articles/PMC3480870/ /pubmed/23115480 http://dx.doi.org/10.4137/CMAMD.S10272 Text en © 2012 the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited. |
spellingShingle | Original Research Shimojima, Yasuhiro Ishii, Wataru Matsuda, Masayuki Ikeda, Shu-ichi Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission |
title | Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission |
title_full | Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission |
title_fullStr | Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission |
title_full_unstemmed | Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission |
title_short | Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission |
title_sort | phenotypes of peripheral blood lymphocytes and cytokine expression in polymyositis and dermatomyositis before treatment and after clinical remission |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480870/ https://www.ncbi.nlm.nih.gov/pubmed/23115480 http://dx.doi.org/10.4137/CMAMD.S10272 |
work_keys_str_mv | AT shimojimayasuhiro phenotypesofperipheralbloodlymphocytesandcytokineexpressioninpolymyositisanddermatomyositisbeforetreatmentandafterclinicalremission AT ishiiwataru phenotypesofperipheralbloodlymphocytesandcytokineexpressioninpolymyositisanddermatomyositisbeforetreatmentandafterclinicalremission AT matsudamasayuki phenotypesofperipheralbloodlymphocytesandcytokineexpressioninpolymyositisanddermatomyositisbeforetreatmentandafterclinicalremission AT ikedashuichi phenotypesofperipheralbloodlymphocytesandcytokineexpressioninpolymyositisanddermatomyositisbeforetreatmentandafterclinicalremission |